Skip to main content
. 2021 Mar 18;8:633590. doi: 10.3389/fmolb.2021.633590

FIGURE 2.

FIGURE 2

A 69 years old male with hepatocellular carcinoma (HCC) has undergone transarterial chemoembolization (TACE). Early TACE refractoriness is found after two consecutive TACE procedures. The baseline dynamic MR shows an 11 cm tumor with heterogeneous enhancement (A, B). The first follow-up dynamic MR shows a viable tumor >50% (C, D), and the second follow-up dynamic CT also shows a viable tumor >50% (E, F).